Using this approach, the authors identified a population of high-PD-L1+, CD25+ Tregs (PD-L1hi Tregs) that was preferentially expressed within tumor tissues and correlated with PD-1 expression in tumor-infiltrating CD8+ T-cells. This evidence concerns the gene PDCD1 and neoplasm.